Table 3:
Variables | Percentage (%) | Baseline: HIV (−) | P value | |
---|---|---|---|---|
HIV (−) | HIV (+) | |||
Age > 60 yo | 53.3% | 16.0% | OR = 0.16 (0.05 – 0,5) | P < 0.001 |
Male sex | 72.0% | 88.0% | OR = 2.98 (0.86 – 10.2) | P = 0.08 |
Cirrhosis | 96.7% | 88.0% | OR = 0.25 (0.06 – 1.0) | P = 0.05 |
Alcohol consumption | 33.4% | 44.0% | OR = 1.56 (0.67 – 3.59) | P = 0.29 |
Symptoms at diagnosis | 30.1% | 24.0% | OR = 0.73 (0.28 – 1.9) | P = 0.52 |
Child B-C | 35.5% | 20.0% | OR = 0.45 (0.16 – 1.25) | P = 0.12 |
BCLC C-D | 38.0% | 40.0% | OR = 1.08 (0.46 – 2.52) | P = 0.84 |
≥ 4 Lesions | 12.8% | 4.0% | OR = 0.28 (0.37 – 2.17) | P = 0.22 |
Largest lesion ≥ 5 cm | 36.7% | 32.0% | OR = 0.8 (0.33 – 1.95) | P = 0.63 |
AFP > 500 ng/mL | 26.8% | 20.0% | OR = 0.68 (0.24 – 1.88) | P = 0.46 |
Extravascular metastasis | 7.8% | 8.0% | OR = 1.02 (0.22 – 4.66) | P = 0.97 |
Tumoral portal vein thrombosis | 11% | 32.0% | OR = 3.74 (1.47 – 9.50) | P = 0.003 |
Treatment | 86.3% | 60% | OR = 0.23 (0.09 – 0.57) | P = 0.001 |
Note: HIV: Human immunodeficiency virus; BCLC: Barcelona Clinic Liver Cancer; AFP: alpha- fetoprotein.